• Embed Doc
  • Readcast
  • Collections
  • CommentGo Back
Download
 
A Feasibility Study of RemoteMonitoring of CAPD Patient’sBlood Pressure and BloodGlucose Measurements Via theInternet
G. Pylypchuck, P. Jacobson, C. McAllister 
 
University of Saskatchewan, St Paul’s Hospital, Department of Nephrology
,
ChroniCare
 
 
Abstract
A FEASIBILITY STUDY OF REMOTE MONITORING OF CAPD PATIENT’S BLOOD PRESSURE ANDBLOOD GLUCOSE MEASUREMENTS VIA THE INTERNET.
G. Pylypchuk, P. Jacobson, C. McAllister University of Saskatchewan, St. Paul’s Hospital, Saskatoon, Saskatchewan. ChroniCare, Regina, Saskatchewan
The purpose of this study was to determine the feasibility of remotely monitoring blood pressure (BP) andglucose measurements in a cohort of diabetic patients receiving continuous ambulatory peritonealdialysis (CAPD). This can be achieved using BP monitors, glucometers and a ChroniCare appliance(HealthGate) to transmit the data to a secure internet server over a home telephone access. Tightcontrol of BP and blood sugar has been proven to improve both mortality and renal function in diabeticpatients with end stage renal disease. Physician access to real time BP and glucose measurementsvia the internet may allow for better control of these clinical parameters over time. Seventeen diabeticpatients currently monitored by St. Paul’s Hospital dialysis unit were selected to trial this equipment.After three initial hospital visits for baseline measurement of BP, glucose, hemoglobin A1c andequipment education, subjects were instructed to continue monitoring their BP and glucose levels atthe same intervals conducted at home. Subjects were instructed to download their data via telephoneline access on a weekly basis. Patients were provided with satisfaction questionnaires to becompleted at the end of the trial. The BP and glucose data could then be monitored in real time viainternet access from any location. Subjects began the study with a mean BP of 147/72 +/- 24/18mmHg, and a mean Hemoglobin A1c level of 7.6
±
1.2%. Baseline BP, glucose and Hemoglobin A1clevels were compared to values at the end of the study. The mean number of values downloaded per week was 11.9
±
11.2 with a range between 2 and 48. Of 17 subjects who began the trial, 15 havebeen successfully transmitting data on a regular basis. One subject refused to use the equipment after completing the initial visits and education and two have been experiencing technical difficulties. It waspossible to view the continuous trend of these vital signs in real time. Data was immediately availableusing internet access and can be viewed in both tabular and graphical formats. Limits may be set for each parameter to notify the physicians when dangerous values are recorded. This data may be usedin the future studies to make meaningful changes to the patients’ medication regimens. CAPDpatients only come to the hospital for follow-up every 2-3 months and it is hypothesized that this toolwill allow more rapid changes in treatment effects and patient compliance. Future studies are plannedto determine the long term effectiveness of this tool on BP and glucose control in this patientpopulation.
 
 
Introduction
Many patients treated with continuous ambulatory peritoneal dialysis (CAPD) live inlocations remote from their active dialysis center. These patients are seen bytheir nephrologist on average once every three months at the dialysis center.Apart from these visits, routine management of both dialysis and their co morbidconditions depends upon decisions of the patient and their family physician.Many patients live long distances from the dialysis center making more frequentfollow up both difficult and expensive.Two of the most common co morbidities affecting peritoneal dialysis patients arediabetes and hypertension. Many studies have proven that tight control of bloodglucose and blood pressure improve both mortality and renal function in diabeticpatients with end stage renal disease. Current practice leaves routine monitoringof these critical parameters up to the patient. Records of self assessment arekept by each patient and are evaluated at each follow up visit with the familyphysician or nephrologist. Subsequent diagnostic decisions are based upon thepatients self reporting of blood sugar and blood pressure measurements take athome.
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...